We wish to inform you that pursuant to Schedule IV of the Companies Act, 2013 and Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Separate Meeting of the independent Directors was held on today i.e. March 27, 2026
Outcome of the separate meeting of independent directors of the company held on 27.03.2026
View original source (BSE India)Trident Texofab Ltd. on 6ix
Earlier from Trident Texofab
- Trident Texofab Ltd. Press Release Feb 12 2026
- Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31.12.2025
- Result- Financial Result Of The Quarter And Nine Months Ended 31St December, 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On February 12, 2026
- Trident Texofab Ltd. Press Release Feb 06 2026
Later from Trident Texofab
- Closure of Trading Window
- Trident Texofab Ltd. Press Release Mar 30 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Trident Texofab Ltd. Press Release Apr 08 2026
- Reply to the clarification sought on price movement
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab